Mission:  promote ovarian cancer awareness and education; support those diagnosed and survivors; and advocate for public policy and funding.

Webinars and Teleconferences

Webinars and teleconferences are hosted by different organizations on different topics. Most webinars last about an hour, are scheduled on a set date at a set time, and require pre-registration. Many are then offered later in an archived version so that someone may watch and/or listen to the taped version of the earlier webinar.

Our calendar will list webinars and teleconferences on the date they are initially offered. Refer to the resource list (to the right) for a list of archived teleconferences and webinars.

Upcoming Webinars & Teleconferences

    • 27 Jan 2022
    • 5:00 PM - 6:15 PM
    • Zoom Audio/Video
    Register


    Personalized Medicine, Clinical Trials, and New Anticancer Treatments

    January 27, 5pm-6:15pm

    Zoom Audio/Video (Login Information in Registration Confirmation)

    It is a truly remarkable time for developing new treatments for cancer. Increasing understanding of cancer biology and the ability to design new drugs to target abnormalities present in cancer has resulted in a number of novel anticancer drugs being approved by the FDA. There are now drugs that either block specific genetic changes in cancer, modulate the immune system, or represent ways to selectively deliver high doses of chemotherapies to the tumor with acceptable safety profiles. These “new drugs” go through very rigorous testing in the laboratory, and only if they meet certain criteria as anticancer agents, are they brought forward to clinical trials. Early-phase trials are used to test new treatments for cancer while ensuring the highest standards of patient safety. Based on findings in tumor samples and patient characteristics we can now better select new treatments which have a higher likelihood to help patients, a process referred to as ‘personalized medicine’. During this talk we will discuss the concept of personalized medicine, phases of clinical trials, and development of new anticancer treatments.

    There will be a Q&A segment after the presentation.

    About the Presenters:

    Upon completing her medical degree from Lady Hardinge Medical College in New Delhi, India, Dr. Shivaani Kummar moved to the United States to train in Internal Medicine at Emory University in Atlanta, Georgia. Following this, Dr. Kummar pursued fellowship training at the National Institute of Health (NIH) in Medical Oncology and Hematology, which culminated in a faculty position at Yale University, New Haven CT. After spending four years as Assistant Professor of Medicine at Yale Cancer Center, she moved back to the National Cancer Institute (NCI), NIH, where she developed a clinical research program in novel cancer therapeutics. In 2011, she became Head of Early Clinical Trials Development in the Office of the Director, Division of Cancer Treatment and Diagnosis, NCI. Dr. Kummar moved to Stanford University in 2015 as Professor of Medicine and Director of the Phase I Clinical Research and Translational Oncology Programs. In July 2020, she joined Oregon Health & Science University (OHSU) as Division Chief of Hematology and Medical Oncology, co-Director of the Center of Experimental Therapeutics, DeArmond Endowed Chair of Cancer Research, and Associate Director for Clinical and Translational Research, Knight Cancer Institute, OHSU. Her research interests focus on developing novel therapies for cancer. She specializes in conducting pharmacokinetic and pharmacodynamic driven first-in-human trials tailored to make early, informed decisions regarding the suitability of novel molecular agents for further clinical investigation. Dr. Kummar is the principal investigator of numerous early phase trials, member of NIH grant review committees and national and international scientific committees

    Dr. Tanja Pejovic is a Professor of Gynecologic Oncology in the Department of Obstetrics and Gynecology at Oregon Health & Science University (OHSU). She is a trained clinician-scientist, with a background in cytogenetic and molecular genetics of ovarian cancer. Dr. Pejovic's PhD thesis entitled “Cytogenetic Analysis of Ovarian Tumors” was, at the time, the largest series of cytogenetically characterized ovarian cancers. As part of Felix Mitelman’s research group, in Lund, Sweden, she was the first to describe recurrent cytogenetic changes, such as the 19p13+ marker chromosome and the deletion of 11p13-15 in epithelial ovarian cancer, as well as trisomy 12 in benign ovarian tumors. At OHSU, Dr. Pejovic maintains a prospective ovarian tissue and blood bank (Oregon Ovarian Cancer Registry), accompanied by a clinical database, unique in the state with over 500 participants. It is a research bank of ovarian tissue specimens accompanied by extensive clinical and outcome data to help further elucidate the mechanisms by which ovarian cancers progress. OOCR is recognized as a major contributor to the international consortium OCAC (Ovarian Cancer Association Consortium), Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) and Ovarian Tumor Tissue Association (OTTA).

    Please note: login information will be included in event registration confirmation and event reminder emails. We are unable to monitor emails for login information during live events.

    • 17 Feb 2022
    • 4:00 PM - 5:00 PM
    • Zoom Video/Audio Conference
    Register

    Virtual Support Group via Zoom

    February 17, 4-5pm

    Join us for a virtual support group facilitated by Susan Hedlund, M.S.W., L.C.S.W., O.S.W.-C., Director, Patient/Family Support Services, OHSU Knight Cancer Institute, School of Medicine.

    Our virtual support group is designed to serve ovarian cancer survivors who share about their personal diagnosis and journey; find comfort and support within the group; and gain information from others’ experience and knowledge.

    Please contact info@ovariancancerosw.org with questions/topics you’d like Susan to address.

    Please register for this event: your event registration confirmation and event reminders will include Zoom meeting login information. We are unable to monitor emails for login information during live events. 

    • 09 Mar 2022
    • 5:00 PM - 6:15 PM
    • Zoom Audio/Video
    Register

    Coping with Chemotherapy

    March 9, 5:00pm-6:15pm

    Zoom Audio/Video (Login Information in Registration Confirmation)

    Everyone’s chemotherapy experience is different, both physically and emotionally. Each person experiences side effects from chemotherapy differently, and different chemotherapy drugs cause different side effects. 

    This session will cover the following:

    • Taking an active role in your care
    • Understanding chemotherapy
    • Most common types of chemotherapy, including immunotherapy and oral PARP inhibitors
    • Understanding and managing the side effects of chemotherapy
    • Communicating with your healthcare team

    About the Presenter:

    Andrea Hardy, RN, BSN, is a Gynecologic Oncology Nurse Care Coordinator at Providence Medical Center. She cares for patients with gynecologic cancer throughout their diagnosis, treatment, and survivorship. Among her various nursing services, Andrea provides patient education, specifically with starting chemotherapy, and over the course of treatment for symptom management. This support helps to ease the journey into the unknown and empowers patients to participate in their own health care.

    Andrea states, “The role of a patient educator is a great privilege in my nursing work with patients. And I appreciate having the opportunity to develop close working relationships with patients over the course of their treatment and medical care."

    A native Oregonian, Andrea enjoys running, hiking/ backpacking in nature with her pup, Finlee, gardening, cooking/ baking, and sharing time with family and friends.

    Please note: login information will be included in event registration confirmation and event reminder emails. We are unable to monitor emails for login information during live events.

    • 18 Mar 2022
    • 4:00 PM - 5:00 PM
    • Zoom Video/Audio Conference
    Register

    Virtual Support Group via Zoom

    March 18, 4-5pm

    Join us for a virtual support group facilitated by Susan Hedlund, M.S.W., L.C.S.W., O.S.W.-C., Director, Patient/Family Support Services, OHSU Knight Cancer Institute, School of Medicine.

    Our virtual support group is designed to serve ovarian cancer survivors who share about their personal diagnosis and journey; find comfort and support within the group; and gain information from others’ experience and knowledge.

    Please contact info@ovariancancerosw.org with questions/topics you’d like Susan to address.

    Please register for this event: your event registration confirmation and event reminders will include Zoom meeting login information. We are unable to monitor emails for login information during live events. 

Re-playable Webinars & Teleconferences

13 Jan 2022 Virtual Support Group Facilitated by Susan Hedlund
10 Dec 2021 Virtual Support Group Facilitated by Susan Hedlund
19 Nov 2021 Virtual Support Group Facilitated by Susan Hedlund
17 Nov 2021 Mindfulness
21 Oct 2021 Virtual Support Group Facilitated by Susan Hedlund
13 Oct 2021 Fear of Recurrence
16 Sep 2021 Virtual Support Group Facilitated by Susan Hedlund
19 Aug 2021 Virtual Support Group Facilitated by Susan Hedlund
11 Aug 2021 Women's Sexual Health After Cancer
15 Jul 2021 Virtual Support Group Facilitated by Susan Hedlund
22 Jun 2021 Virtual 2021 Ovarian Cancer Medical Update
04 Jun 2021 Virtual Support Group Facilitated by Susan Hedlund
18 May 2021 Tumor Profiling & Treatment Presentation
06 May 2021 Virtual Support Group Facilitated by Susan Hedlund
14 Apr 2021 Insights into Naturopathic Medicine
17 Feb 2021 Survivorship Tips, Now What....
11 Jan 2021 Palliative Care Educational Session
23 Jun 2020 Virtual 2020 Ovarian Cancer Medical Update
20 Dec 2017 Webinar: BRCA Genetics in the News by Sharsheret
18 Dec 2017 Facebook Live with Dr. Bruegl and Survivor Becki McC
09 Feb 2017 Webinar: Clinical Trials for Ovarian Cancer -- Fact v. Fiction
06 Feb 2017 Webinar: Update on ACA and public policy with OCRFA Chad Ramsey
28 Nov 2016 Webinar: Managing Recurrence -- What You Need to Know
26 Oct 2016 Webinar: Info Session on Becoming a Scientific Research Advocate
06 Oct 2016 SHARE webinar: Fear of Recurrence for Breast and Ovarian Cancer Survivors
22 Sep 2016 Webinar: Stand Up to Cancer Ovarian Cancer Dream Team Update
20 Sep 2016 CancerCare webinar: Update on ADVANCED Ovarian Cancer
15 Sep 2016 SHARE webinar: Strategies for Long-term Management of Recurrent Ovarian Cancer
07 Sep 2016 CancerCare webinar: Update on Ovarian Cancer
02 Sep 2016 Archive Webinar: Highlights from 2016 ASCO (American Society of Clinical Oncology) meeting
28 Apr 2015 CancerCare Web/Pod Cast on Ovarian Cancer
18 Oct 2014 Nutrition for Ovarian Cancer Survivors, OCRF Webinar Series
30 Sep 2014 Breast and Ovarian Cancer, OCRF Webinar Series
24 Apr 2014 Breakthroughs in Small Cell Carcinoma, OCRF Webinar Series

Resource list of teleconferences, webinars and videos

Log in

Ovarian Cancer Alliance of Oregon and Southwest Washington
16420 SE McGillivray, Suite 103, PMB 243  
Vancouver, WA 98683-3461
(877) 682-2679        info@ovariancancerosw.org

We are a registered 501(c)(3) Non-Proft Corporation. EIN: 20-2558493
Copyright © 2005-2019 Ovarian Cancer Alliance of Oregon and Southwest Washington. All rights reserved.

Powered by Wild Apricot Membership Software